Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for downregulating CCR5 in T cells with anti-CD3 antibodies and anti-CD28 antibodies

Methods for downregulating CCR5 in T cells with anti-CD3 antibodies and anti-CD28 antibodies

US Patent 7927595 · Granted Apr 19, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Non-signaling HIV fusion inhibitors and methods of use thereof2025
Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosi2025
Switch costimulatory receptors2025
Compositions and methods for generating a persisting population of T cells usefu2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
Altering gene expression in cart cells and uses thereof2025
Use of trans-signaling approach in chimeric antigen receptors2025
Methods for improving the efficacy and expansion of immune cells2025
Methods for improving the efficacy and expansion of immune cells2025
Use of the CD2 signaling domain in second-generation chimeric antigen receptors2025
Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against 2025
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor2025